Therapeutic development
Develops therapeutics targeting muscle and the central nervous system to address the root cause of disease.
Source: LinkedIn company description · Retrieved October 13, 2026
Dyne Therapeutics focuses on developing treatments for people living with genetically driven neuromuscular diseases.
The company is developing therapeutics targeting muscle and the central nervous system to address disease causes. Its clinical programs address Duchenne muscular dystrophy and myotonic dystrophy type 1; its preclinical programs address facioscapulohumeral muscular dystrophy and Pompe disease.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Develops therapeutics targeting muscle and the central nervous system to address the root cause of disease.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026, September 19, 2026 and September 21, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.